Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapyMaria Hägg Olofsson, Takayuki Ueno, Yang Pan, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 31, 2019
Portoamides A and B are mitochondrial toxins and induce cytotoxicity on the proliferative cell layer of in vitro microtumoursMaria Lígia Sousa, Tiago Ribeiro, Vítor Vasconcelos, et al.
Frontiers in Oncology|June 19, 2023
Corrigendum: Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylationMaria Lígia Sousa, Marco Preto, Vítor Vasconcelos, et al.
Frontiers in Oncology|April 20, 2019
Antiproliferative Effects of the Natural Oxadiazine Nocuolin A Are Associated With Impairment of Mitochondrial Oxidative PhosphorylationMaria Lígia Sousa, Marco Preto, Vítor Vasconcelos, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 16, 2008
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activityTakayuki Ueno, Göran Elmberger, Timothy E Weaver, et al.
Molecular Oncology|April 23, 2009
3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugsLinda Strandberg Ihrlund, Emma Hernlund, Omar Khan, et al.
Free Radical Biology & Medicine|March 31, 2009
Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocationEmma Hernlund, Ozgur Kutuk, Huveyda Basaga, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 31, 2012
A natural anticancer agent thaspine targets human topoisomerase IBSilvia Castelli, Prafulla Katkar, Oscar Vassallo, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 18, 2015
Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?Karthik Selvaraju, Magdalena Mazurkiewicz, Xin Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2013
A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cellsDhifaf Sarhan, Erik Wennerberg, Padraig D'Arcy, et al.
Pageof 13